| Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease JG Goldman, S Holden, B Bernard, B Ouyang, CG Goetz, GT Stebbins Movement Disorders 28 (14), 1972-1979, 2013 | 158 | 2013 |
| Diagnosing PD‐MCI by MDS task force criteria: How many and which neuropsychological tests? JG Goldman, S Holden, B Ouyang, B Bernard, CG Goetz, GT Stebbins Movement Disorders 30 (3), 402-406, 2015 | 156 | 2015 |
| Treatment of psychosis and dementia in Parkinson’s disease JG Goldman, S Holden Current treatment options in neurology 16, 1-18, 2014 | 152 | 2014 |
| Progression of MDS‐UPDRS scores over five years in de novo Parkinson disease from the Parkinson's progression markers initiative cohort SK Holden, T Finseth, SH Sillau, BD Berman Movement disorders clinical practice 5 (1), 47-53, 2018 | 148 | 2018 |
| Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment JG Goldman, SK Holden, I Litvan, I McKeith, GT Stebbins, JP Taylor Movement Disorders 33 (4), 503-510, 2018 | 80 | 2018 |
| Implementation issues relevant to outpatient neurology palliative care BM Kluger, MJ Persenaire, SK Holden, LT Palmer, HM Redwine, J Berk, ... Annals of palliative medicine 7 (3), 33948-33348, 2018 | 46 | 2018 |
| Update on posterior cortical atrophy SK Holden, BM Bettcher, VS Pelak Current opinion in neurology 33 (1), 68-73, 2020 | 33 | 2020 |
| Feasibility of home-based neurologic music therapy for behavioral and psychological symptoms of dementia: A pilot study SK Holden, J Sheffler, R Stewart, S Thompson, J Persson, T Finseth, ... Journal of music therapy 56 (3), 265-286, 2019 | 33 | 2019 |
| Outcome measures for Parkinson's disease dementia: a systematic review SK Holden, WE Jones, KA Baker, IM Boersma, BM Kluger Movement disorders clinical practice 3 (1), 9-18, 2016 | 24 | 2016 |
| Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease SK Holden, LD Medina, B Hoyt, SH Sillau, BD Berman, JG Goldman, ... Movement Disorders 33 (11), 1760-1768, 2018 | 22 | 2018 |
| Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison SK Holden, CE Koljack, LP Prizer, SH Sillau, JM Miyasaki, BM Kluger Parkinsonism & related disorders 65, 172-177, 2019 | 20 | 2019 |
| Sex differences in dementia with Lewy bodies: Focused review of available evidence and future directions SY Chiu, KA Wyman-Chick, TJ Ferman, E Bayram, SK Holden, ... Parkinsonism & related disorders 107, 105285, 2023 | 18 | 2023 |
| Fluid and tissue biomarkers of Lewy body dementia: report of an LBDA symposium GD Scott, MR Arnold, TG Beach, CH Gibbons, AG Kanthasamy, ... Frontiers in neurology 12, 805135, 2022 | 17 | 2022 |
| Psychiatric comorbidities in functional movement disorders: a retrospective cohort study ZA Macchi, I Kletenik, C Olvera, SK Holden Movement disorders clinical practice 8 (5), 725-732, 2021 | 17 | 2021 |
| Higher risk, higher reward? Self‐reported effects of real‐world cannabis use in Parkinson's disease SK Holden, CH Domen, S Sillau, Y Liu, MA Leehey Movement Disorders Clinical Practice 9 (3), 340-350, 2022 | 11 | 2022 |
| Lewy body dementia association’s research centers of excellence program: inaugural meeting proceedings B Peterson, M Armstrong, D Galasko, JE Galvin, J Goldman, D Irwin, ... Alzheimer's research & therapy 11, 1-4, 2019 | 10 | 2019 |
| Co-occurrence of convergence insufficiency and cognitive impairment in parkinsonian disorders: a pilot study SK Holden, E Van Dok, VS Pelak Frontiers in neurology 10, 469996, 2019 | 10 | 2019 |
| Profiling Parkinson’s disease cognitive phenotypes via resting-state magnetoencephalography OB Simon, DC Rojas, D Ghosh, X Yang, SE Rogers, CS Martin, ... Journal of neurophysiology 127 (1), 279-289, 2022 | 8 | 2022 |
| A high-current ion implanter system M Nasser-Ghodsi, M Farley, J Grant, D Bernhardt, M Foley, S Holden, ... Nuclear Instruments and Methods in Physics Research Section B: Beam …, 1991 | 8 | 1991 |
| Randomized controlled trial of neurologic music therapy in Parkinson’s disease: research rehabilitation protocols for mechanistic and clinical investigations I Buard, L Lattanzio, R Stewart, S Thompson, K Sjoberg, K Hookstadt, ... Trials 22 (1), 577, 2021 | 7 | 2021 |
Jennifer G. Goldman, MD, MSShirley Ryan AbilityLab and Northwestern UniversityПідтверджена електронна адреса в sralab.org
